SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-004376
Filing Date
2020-01-15
Accepted
2020-01-15 17:45:59
Documents
2
Period of Report
2020-01-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm203470d1_3.html 3  
1 OWNERSHIP DOCUMENT tm203470d1_3.xml 3 1626
2 EXHIBIT 24.1 tm203470d1_ex24-1.htm EX-24.1 11507
  Complete submission text file 0001104659-20-004376.txt   14541
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARMISTICE CAPITAL 510 MADISON AVE., 7TH FLOOR NEW YORK NY 10022
Business Address
Maher Illya Keith (Reporting) CIK: 0001792777 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36672 | Film No.: 20528994